Immunohistochemical phenotype of malignant mesothelioma: Predictive value of CA125 and HBME-1 expression

Histopathology

Volumn 30, Issue 1, 1997, Pages 49-56

  Bateman, A C ^a,c   Al Talib, R K ^b   Newman, T ^a   Williams, J H ^a   Herbert, A ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^c QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

adenocarcinoma; immunohistochemistry; malignant mesothelioma

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESOTHELIOMA; PRIORITY JOURNAL;

EID: 0031034824     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-562.x     Document Type: Article

References (19)

1. Skov BG, Lauritzen AF, Hirsch F, Nielsen HW. The histopathological diagnosis of malignant mesothelioma vs. pulmonary adenocarcinoma: reproducibility of the histopathological diagnosis. Histopathology 1994: 24; 553-557.
2. Brown RW, Clark GM, Tandon AK, Allred DC. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum. Pathol. 1993: 24; 347-353.
3. Skov BG, Lauritzen AF, Hirsch FR, Skov T, Nielsen HW. Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies. Histopathology 1994: 25; 431-437.
4. Otis CN, Carter D, Cole S, Battifora H. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. Am. J. Surg. Pathol. 1987: 11; 445-456.
5. Wirth PR, Legier J, Wright GL. Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma. Cancer 1991: 67; 655-662.
6. Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp BC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 1981: 68; 1331-1337.
7. Nouwen EJ, Pollet DE, Eedekens MW, Hendrix PG, Briers TW, De Broe ME. Immunohistochemical localisation of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung. Cancer Res. 1986: 46; 866-876.
8. Sheibani K, Esteban JM, Bailey A, Battifora H, Weiss LM. Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum. Pathol. 1992: 23; 107-115.
9. Gerdes J, Becker MHG, Key G, Cattoretti G. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J. Pathol. 1992: 168; 85.
10. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave processed formalin-fixed paraffin sections. J. Pathol. 1992: 168; 357-63.
11. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 1981: 29; 577-80.
12. Schofield JB, Krausz T. Metastatic disease and lymphomas. In Gray W ed. Diagnostic cytopathology. Hong Kong: Churchill Livingstone, 1995 149-194.
13. Moch H, Oberholzer M, Dalquen P, Wegmann W, Gudat F. Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: immunohistochemical findings. Virchows Archiv. A Pathol. Anat. 1995: 423; 19-27.
14. Anderson TM, Holmes EC, Kosaka CJ et al. Monoclonal antibodies to human malignant mesothelioma. J. Clin. Immunol. 1987: 7; 254-261.
15. Hsu SM, Hsu PL, Zhao X et al. Establishment of human mesothelioma cell lines (MS-1, -2) and production of a monoclonal antibody (anti-MS) with diagnostic and therapeutic potential. Cancer Res. 1988: 48; 5228-5236.
16. Gitsch G, Tabery U, Feigl W, Breitenecker G. The differential diagnosis of primary peritoneal papillary tumours. Arch. Gynaecol. Obstet. 1992: 251; 139-144.
17. Delahaye M, Hoogsteden HC, van der Kwast THW. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma. J. Pathol. 1991: 165; 137-143.
18. Battifora H, Elliott McCaughey WT. Tumours of the serosal membranes. Atlas of Tumour Pathology, 3rd series, Fascicle 25. Washington DC: Armed Forces Institute of Pathology, 1994.
19. Bolen JW, Hammar SP, McNutt MA. Reactive and neoplastic serosal tissue. A light-microscopic, ultrastructural, and immunocytochemical study. Am. J. Surg. Pathol. 1986: 10; 34-47.